Vertex Pharmaceuticals

Quarterly Financials

Values in thousands2026-03-312025-12-312025-09-302025-06-30
Revenue
$2,986,900
$3,227,100
$3,076,400
$2,964,700
Gross Profit
2,594,100
2,761,100
2,661,600
2,557,200
EBITDA
1,138,100
1,353,500
1,356,100
1,338,400
EBIT
1,300,400
1,302,100
1,286,700
Net Income
1,031,400
1,191,100
1,082,900
1,032,900
Net Change In Cash
2,986,900
3,227,100
3,076,400
2,964,700
Free Cash Flow
1,294,700
348,600
1,139,600
927,400
Cash
5,492,900
5,087,800
4,939,600
4,972,200
Basic Shares
256,300
256,100
257,600
258,900

Annual Financials

Values in thousands2025-12-312024-12-312023-12-312022-12-31
Revenue
$12,074,600
$11,020,100
$9,869,200
$8,930,700
Gross Profit
10,267,500
9,489,600
8,607,000
7,850,400
EBITDA
4,967,900
486,300
4,605,200
4,435,500
EBIT
4,760,700
280,500
4,423,900
4,287,200
Net Income
3,953,200
-535,600
3,619,600
3,322,000
Net Change In Cash
12,074,600
11,020,100
9,869,200
8,930,700
Cost of Revenue
3,741,100
Free Cash Flow
3,193,800
-790,300
3,278,900
3,925,200
Cash
5,087,800
4,569,600
10,369,100
10,504,000
Basic Shares
258,000
257,900
260,500
259,100

Earnings Calls

QuarterEPS
2026-03-31
$4.47
2025-12-31
$5.03
2025-09-30
$4.80
2025-06-30
$4.52